Exonucleases MarketThe global exonucleases market, valued at approximately USD 162.6 million in 2022, is on track for steady growth over the next decade. Forecasts indicate a compound annual growth ...
Centivax partners with BioCina to initiate cGMP manufacturing of revolutionary universal influenza vaccine: Adelaide, South Australia Monday, October 14, 2024, 11:00 Hrs [IST] Bio ...
Nanotein Technologies is a Berkeley-based, Series-A biotechnology start-up manufacturing next generation reagents that expand and activate immune cells for Cell Therapy applications. Research use only ...
In lab experiments, bacteria transferred plasmids with AMR genes in the presence of zinc at reduced or nonexistent rates. Stopping the transfer without killing microbes may help reduce AMR without ...
Thierry Bordet, CSO of PulseSight Therapeutics, said, “EVER attracts top European researchers and the most innovative industry players, and I am delighted that we have been accepted to present our ...